More recently, Hermann et al. showed that CD133+CXCR4+ pancreatic cancer cells have high metastatic potential and depletion of these CD133+CXCR4+ cells abrogated the metastatic potential. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.